ESG

The Sugar Ray Leonard Foundation's 15th annual charity boxing night will honor Dr. Jennifer Raymond for her groundbreaking work in pediatric diabetes care.

A new partnership transforms Raleigh bus shelters into platforms for life-saving messages, tackling underage drinking one commute at a time.

The Aesthetic Syndicate evolves into Manor, launching a national brand that fuses injectables with medically supervised GLP-1 therapy and holistic health.

Lighthouse Autism Center is opening a new facility, promising to reduce wait times and provide integrated diagnostic and ABA therapy for local families.

A new risk-sharing facility aims to unlock INR 250 crore in green loans for nano-entrepreneurs, boosting incomes and advancing India's climate goals.

Amid a shocking rise in carbon monoxide fatalities, new detectors from Kidde offer advanced low-level warnings to protect vulnerable family members.

Tunnell Consulting's perfect CMMC score reveals a cost-effective enclave strategy, challenging the belief that compliance must be an expensive overhaul.

After a 'divine' tasting and a major award, Boston's GALY is scaling its tank-grown cocoa and cotton, promising a radical shift in global supply chains.

The waffle giant is helping restaurants meet health demands with simple add-ins that boost nutrition without disrupting kitchen workflow or taste.

A new all-in-one system from Sweden's Multi4 Medical just won EU approval, allowing urologists to treat bladder cancer in minutes without surgery.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

Schindler's new ReStore and ReNew packages offer a cost-effective, high-tech upgrade for aging hydraulic elevators, boosting efficiency and reliability.

As Ricardé Paris claims to lead a 'Quiet Luxury' revival, the market sends mixed signals. Is understated elegance the future or a fading trend?

A new FDA-cleared system offers hope against postpartum hemorrhage, the leading cause of maternal death, earning its maker a prestigious Edison Award.

A $33M C-PACE deal for a Deepak Chopra-affiliated resort shows how innovative financing is reshaping real estate development in a tight market.

Responding to geopolitical risks, Telenor is launching a new company to provide a secure, nationally controlled cloud for Norway's most sensitive data.